Výsledky vyhledávání - "The TIMI Investigators"

Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial

Autor: Eugene Braunwald, Wingham J Kwong, Christian T. Ruff, Elizabeth A. Magnuson, Engage Af-Timi Investigators, Robert P. Giugliano, Elliott M. Antman, Haiyan Li, David J. Cohen, Katherine Vilain

Publikováno v: Circulation: Cardiovascular Quality and Outcomes. 13

Background The ENGAGE AF–TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) demonstrated noninferiority of once-daily 60 mg (30 mg dose-reduced) edoxaban compar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5e6edb0f446e566ed7e5d51b265083
https://doi.org/10.1161/circoutcomes.120.006511

Zobrazit plný text záznamu

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation

Autor: Elliott M. Antman, Michele Mercuri, Eugene Braunwald, Alvin Chandra, Scott D. Solomon, Deepak K. Gupta, Christian T. Ruff, Robert P. Giugliano, Michael A. Grosso, Riccardo M. Inciardi, Engage Af-Timi Investigators, Brian Claggett

Publikováno v: Eur J Heart Fail

Aims The present study aimed to assess the association between left atrial (LA) structure and function and the risk for cardiovascular (CV) death or heart failure (HF) hospitalization in a population with atrial fibrillation (AF). Methods and results

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca2d5f1d469998637fe45e511b848b0
https://pubmed.ncbi.nlm.nih.gov/31779052

Zobrazit plný text záznamu

Plný text ve formátu HTML

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

Autor: Savor-Timi Investigators, Yared Gurmu, Benjamin M. Scirica, Ph. Gabriel Steg, Itamar Raz, Christina L. Fanola, Deepak L. Bhatt, Avivit Cahn, Ofri Mosenzon, Brian A. Bergmark

Publikováno v: European heart journal. 39(24)

AIMS: Optimal blood pressure for prevention of cardiovascular (CV) events in patients with Type 2 diabetes mellitus (T2DM) remains uncertain and there is concern for increased risk with low diastolic blood pressure (DBP). This study analysed the asso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692acc73d90acebff92c7a176a84d120
https://pubmed.ncbi.nlm.nih.gov/29394350

Zobrazit plný text záznamu

Recombinant Nematode Anticoagulant Protein c2 in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Autor: Peter Stone, Robert P. Giugliano, Steven R. Deitcher, Alain Bouchard, Daniel I. Simon, Eugene Braunwald, Stephen D. Wiviott, Massoud A. Leesar, Anthem–Timi Investigators, Marc J. Schweiger, Carolyn H. McCabe, Michael A Goulder

Publikováno v: Journal of the American College of Cardiology. 49(25):2398-2407

Objectives We sought to evaluate the safety and efficacy of recombinant nematode anticoagulant protein c2 (rNAPc2) in patients with non–ST-segment elevation acute coronary syndrome (nSTE-ACS). Background Recombinant NAPc2 is a potent inhibitor of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b1d47b05a2897c98430bd72859844f

Zobrazit plný text záznamu

Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial

Autor: Basil S. Lewis, Nathan Roguin, C. Michael Gibson, ExTRACT-TIMI Investigators, Marc Cohen, Eugene Braunwald, Dietrich C. Gulba, Oscar H. Kracoff, Sabina A. Murphy, Diego Ardissino, Gilles Montalescot, Elliott M. Antman, David A. Morrow

Publikováno v: Journal of the American College of Cardiology. 49(23):2238-2246

ObjectivesWe sought to evaluate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH) as adjunctive therapy for patients with ST-segment elevation myocardial infarction (STEMI) who receive fibrinolytic therapy and subsequently undergo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2fc97887df5855ad77e56be46ea9e5f

Zobrazit plný text záznamu

Relationship Between Uncontrolled Risk Factors and C-Reactive Protein Levels in Patients Receiving Standard or Intensive Statin Therapy for Acute Coronary Syndromes in the PROVE IT-TIMI 22 Trial

Autor: Nader Rifai, Prove It-Timi Investigators, Kausik K. Ray, C. Michael Gibson, Paul M. Ridker, Eugene Braunwald, Carolyn H. McCabe, Christopher P. Cannon, Richard Cairns, David A. Morrow, Allan M. Skene, Ajay J. Kirtane

Publikováno v: Journal of the American College of Cardiology. 46:1417-1424

ObjectivesThis study sought to evaluate what set of factors correlate with higher or lower C-reactive protein (CRP) levels in patients receiving standard and intensive statin therapy.BackgroundC-reactive protein levels in blood are becoming recognize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04eb45a136b94b03bd9ce10f3711b5d9
https://doi.org/10.1016/j.jacc.2005.08.024

Zobrazit plný text záznamu

Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

Autor: Marc A. Pfeffer, Eugene Braunwald, Kausik K. Ray, Christopher P. Cannon, Prove It-Timi Investigators, Stephen D. Wiviott, David A. Morrow

Publikováno v: Journal of the American College of Cardiology. 46:1411-1416

OBJECTIVES This study sought to evaluate the safety and efficacy of achieving very low calculated low-density lipoprotein (LDL) levels with intensive statin therapy. BACKGROUND Intensive statin therapy reduces clinical events occurring after acute co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be5e92684664d83dc7606eed9287dfc7
https://doi.org/10.1016/j.jacc.2005.04.064

Zobrazit plný text záznamu

Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease

Autor: Eugene Braunwald, Peter M. DiBattiste, Nasser Lakkis, Marc J. Schweiger, Manu Pillai, Amir Lotfi, Hisham Dokainish, Tactics-Timi Investigators, Sabina A. Murphy, David A. Morrow, Christopher P. Cannon

Publikováno v: Journal of the American College of Cardiology. 45(1):19-24

Objectives The purpose of this study is to determine whether there is clinical significance to elevated troponin I in patients with suspected acute coronary syndromes (ACS) with non-critical angiographic coronary stenosis. Background Elevation of tro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8072564134d95f47ed77b8b22960b393

Zobrazit plný text záznamu

Outcome of Patients With Acute Coronary Syndrome Admitted to Hospitals With or Without Onsite Cardiac Catheterization Laboratory

Autor: Peter M. DiBattiste, Tsyboulev, William S. Weintraub, Nasser Lakkis, Gibson Cm, Sabina A. Murphy, Christopher P. Cannon, Tactics-Timi Investigators

Publikováno v: Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 1:232-237

In the TACTICS-TIMI-18 trial, patients with acute coronary syndrome were treated with aspirin, heparin, and tirofiban and were randomized to an invasive strategy with routine catheterization or to a conservative strategy with catheterization (only if

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3705ee197ca79f6f598cce879f11736
https://doi.org/10.1097/00132577-200212000-00005

Zobrazit plný text záznamu

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial

Autor: Solid-Timi, Investigators, Schoors, Danny

IMPORTANCE Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) has been hypothesized to be involved in atherogenesis through pathways related to inflammation. Darapladib is an oral, selective inhibitor of the Lp-PLA2 enzyme. OBJECTIVE To evaluate t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::a3c79c987fee14c7894a69889fe8d1fd
https://hdl.handle.net/20.500.14017/66133351-14e3-45ec-ae69-42722668e6a2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání